– Interview with Robert Hewitt, Ph.D., CEO, Integrated Biobank of Luxembourg, and European Editor, Biopreservation and Biobanking (published by Mary Ann Liebert, Inc.)

Previous articleDNDi to Search Pfizer’s Chemical Library for Potential HAT, VL, and Chagas Disease Treatments
Next articleNewron Raises CHF 7.9M to Help Progress Clinical Trials and Pipeline Development